Published Date：Dec. 2020
Industry：Pharma & Healthcare
Pages：88 Table Number：90
Single User Price：￥4860.00
Enterprise User Price：￥5800.00
Summary This study analysis was given on a worldwide scale, for instance, present and historical Glaucoma Treatment Drugs growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of Glaucoma Treatment Drugs production, Glaucoma Treatment Drugs revenue, Glaucoma Treatment Drugs consumption and Glaucoma Treatment Drugs price. According to the current situation, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. XYZResearch published a report for global Glaucoma Treatment Drugs market in this environment. In terms of revenue, this research report indicated that the global Glaucoma Treatment Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Glaucoma Treatment Drugs industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the production and revenue data in each of the sub-segments. The ??Aerie Pharmaceuticals aims at producing XX Glaucoma Treatment Drugs in 2020, with XX % production to take place in global market, ????Akorn Inc. accounts for a volume share of XX %. At the upcoming analysis, this report discusses industrial policy, economic environment, in addition to the COVID-19 impact and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Glaucoma Treatment Drugs Market by XYZResearch Include NorthAmerica Asia Europe Middle East & Africa South America Competitive Analysis; Who are the Major Players in Glaucoma Treatment Drugs Market? Aerie Pharmaceuticals Akorn Inc. Alcon Allergan plc Bausch & Lomb Incorporated Inotek Pharmaceuticals Merck & Co. Inc Pfizer Inc Santen Pharmaceutical Co. Ltd Major Type of Glaucoma Treatment Drugs Covered in XYZResearch report: Oral Type Injection Type Application Segments Covered in XYZResearch Market Hospital Clinic Home Care For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Glaucoma Treatment Drugs Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Oral Type -Product Introduction and Major Manufacturers 1.1.2 Injection Type -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Regional Market 2.1 Regional Market Share in Terms of Production (2019-2026) 2.2 Regional Market Share in Terms of Revenue (2019-2026) 2.3 Regional Market Share in Terms of Consumption (2019-2026) 3 Global Glaucoma Treatment Drugs Market Assessment by Type 3.1 Global Glaucoma Treatment Drugs Production by Type (2015-2026) 3.2 Global Glaucoma Treatment Drugs Revenue by Type (2015-2026) 3.3 North America Glaucoma Treatment Drugs Production and Revenue by Type (2015-2026) 3.4 Asia Glaucoma Treatment Drugs Production and Revenue by Type (2015-2026) 3.5 Europe Glaucoma Treatment Drugs Production and Revenue by Type (2015-2026) 3.6 Middle East & Africa Glaucoma Treatment Drugs Production and Revenue by Type (2015-2026) 3.7 South America Glaucoma Treatment Drugs Production and Revenue by Type (2015-2026) 4 Global Glaucoma Treatment Drugs Market Assessment by Application 4.1 Historical & Forecast Global Glaucoma Treatment Drugs Consumption, Different Application Field (2015-2026) 4.2 Historical & Forecast North America Glaucoma Treatment Drugs Consumption, Different Application Field (2015-2026) 4.3 Historical & Forecast Asia Glaucoma Treatment Drugs Consumption, Different Application Field (2015-2026) 4.4 Historical & Forecast Europe Glaucoma Treatment Drugs Consumption, Different Application Field (2015-2026) 4.5 Historical & Forecast Middle East & Africa Glaucoma Treatment Drugs Consumption, Different Application Field (2015-2026) 4.6 Historical & Forecast South America Glaucoma Treatment Drugs Consumption, Different Application Field (2015-2026) 5 North America 5.1 US Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 5.2 Canada Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 5.3 Mexico Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6 Asia 6.1 China Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6.2 Japan Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6.3 India Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6.4 Korea Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 6.5 Southeat Asia Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7 Europe 7.1 Germany Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7.2 UK Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7.3 France Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7.4 Russia Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 7.5 Italy Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8 Middle East and Africa 8.1 Saudi Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8.2 UAE Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8.3 Egypt Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8.4 Nigeria Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 8.5 South Africa Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 9 South America 9.1 Brazil Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 9.2 Argentina Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 9.3 Colombia Glaucoma Treatment Drugs Capacity, Production, Consumption and Proportion of Products Sold (2015-2026) 10 Global Glaucoma Treatment Drugs Average Price Trend 10.1 Market Price for Each Type of Glaucoma Treatment Drugs in North America (2015-2026) 10.2 Market Price for Each Type of Glaucoma Treatment Drugs in Asia (2015-2026) 10.3 Market Price for Each Type of Glaucoma Treatment Drugs in Europe (2015-2026) 10.4 Market Price for Each Type of Glaucoma Treatment Drugs in Middle East & Africa (2015-2026) 10.5 Market Price for Each Type of Glaucoma Treatment Drugs in South America (2015-2026) 11 Value Chain (Impact of COVID-19) 11.1 Glaucoma Treatment Drugs Value Chain Analysis 11.1.1 Upstream 11.1.2 Downstream 11.2 COVID-19 Impact on Glaucoma Treatment Drugs Industry 11.2.1 Industrial Policy Issued Under the Epidemic Situation 11.3 Cost-Under the Epidemic Situation 11.3.1 Cost of Raw Material 11.4 Channel Analysis 11.4.1 Distribution Channel-Under the Epidemic Situation 11.4.2 Distributors 12 Glaucoma Treatment Drugs Competitive Analysis 12.1 Aerie Pharmaceuticals 12.1.1 Aerie Pharmaceuticals Company Profiles 12.1.2 Aerie Pharmaceuticals Product Introduction 12.1.3 Aerie Pharmaceuticals Glaucoma Treatment Drugs Production, Revenue (2015-2020) 12.1.4 SWOT Analysis 12.2 Akorn Inc. 12.2.1 Akorn Inc. Company Profiles 12.2.2 Akorn Inc. Product Introduction 12.2.3 Akorn Inc. Glaucoma Treatment Drugs Production, Revenue (2015-2020) 12.2.4 SWOT Analysis 12.3 Alcon 12.3.1 Alcon Company Profiles 12.3.2 Alcon Product Introduction 12.3.3 Alcon Glaucoma Treatment Drugs Production, Revenue (2015-2020) 12.3.4 SWOT Analysis 12.4 Allergan plc 12.4.1 Allergan plc Company Profiles 12.4.2 Allergan plc Product Introduction 12.4.3 Allergan plc Glaucoma Treatment Drugs Production, Revenue (2015-2020) 12.4.4 SWOT Analysis 12.5 Santen Pharmaceutical Co. Ltd 12.5.1 Bausch & Lomb Incorporated Company Profiles 12.5.2 Bausch & Lomb Incorporated Product Introduction 12.5.3 Bausch & Lomb Incorporated Glaucoma Treatment Drugs Production, Revenue (2015-2020) 12.5.4 SWOT Analysis 12.6 Inotek Pharmaceuticals 12.6.1 Inotek Pharmaceuticals Company Profiles 12.6.2 Inotek Pharmaceuticals Product Introduction 12.6.3 Inotek Pharmaceuticals Glaucoma Treatment Drugs Production, Revenue (2015-2020) 12.6.4 SWOT Analysis 12.7 Merck & Co. Inc 12.7.1 Merck & Co. Inc Company Profiles 12.7.2 Merck & Co. Inc Product Introduction 12.7.3 Merck & Co. Inc Glaucoma Treatment Drugs Production, Revenue (2015-2020) 12.7.4 SWOT Analysis 12.8 Pfizer Inc 12.8.1 Pfizer Inc Company Profiles 12.8.2 Pfizer Inc Product Introduction 12.8.3 Pfizer Inc Glaucoma Treatment Drugs Production, Revenue (2015-2020) 12.8.4 SWOT Analysis 12.9 Santen Pharmaceutical Co. Ltd 12.9.1 Santen Pharmaceutical Co. Ltd Company Profiles 12.9.2 Santen Pharmaceutical Co. Ltd Product Introduction 12.9.3 Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Production, Revenue (2015-2020) 12.9.4 SWOT Analysis 13 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Glaucoma Treatment Drugs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table Regional Market Share in Terms of Production (2019-2026) Figure Regional Market Share in Terms of Production (2019 - 2020) Table Regional Market Share in Terms of Revenue (2019-2026) Figure Regional Market Share in Terms of Revenue (2019 - 2020) Figure Regional Market Share in Terms of Consumption (2019 - 2020) Figure Regional Market Share in Terms of Consumption (2019 - 2020) Table Global Glaucoma Treatment Drugs Production (K Unit) by Type (2015-2026) Figure Global Glaucoma Treatment Drugs Production (K Unit) and Growth Rate (2015-2026) Figure Global Glaucoma Treatment Drugs Production Market Share (%) by Type (2019 -2020) Table Global Glaucoma Treatment Drugs Revenue (Million USD) by Type (2015-2026) Figure Global Glaucoma Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure Global Glaucoma Treatment Drugs Revenue Market Share (%) by Type (2019-2020) Figure North America Glaucoma Treatment Drugs Production (K Unit) by Type (2015-2026) Figure North America Glaucoma Treatment Drugs Production (K Unit) and Growth Rate (2015-2026) Figure North America Glaucoma Treatment Drugs Revenue (Million USD) by Type (2015-2026) Figure North America Glaucoma Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure Asia Glaucoma Treatment Drugs Production (K Unit) by Type (2015-2026) Figure Asia Glaucoma Treatment Drugs Production (K Unit) and Growth Rate (2015-2026) Figure Asia Glaucoma Treatment Drugs Revenue (Million USD) by Type (2015-2026) Figure Asia Glaucoma Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure Europe Glaucoma Treatment Drugs Production (K Unit) by Type (2015-2026) Figure Europe Glaucoma Treatment Drugs Production (K Unit) and Growth Rate (2015-2026) Figure Europe Glaucoma Treatment Drugs Revenue (Million USD) by Type (2015-2026) Figure Europe Glaucoma Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure Middle East & Africa Glaucoma Treatment Drugs Production (K Unit) by Type (2015-2026) Figure Middle East & Africa Glaucoma Treatment Drugs Production (K Unit) and Growth Rate (2015-2026) Figure Middle East & Africa Glaucoma Treatment Drugs Revenue (Million USD) by Type (2015-2026) Figure Middle East & Africa Glaucoma Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2026) Figure South America Glaucoma Treatment Drugs Production (K Unit) by Type (2015-2026) Figure South America Glaucoma Treatment Drugs Production (K Unit) and Growth Rate (2015-2026) Figure South America Glaucoma Treatment Drugs Revenue (Million USD) by Type (2015-2026) Figure South America Glaucoma Treatment Drugs Revenue (Million USD) and Growth Rate (2015-2026) Table Historical & Forecast Glaucoma Treatment Drugs Different Application Field Consumption (K Unit) Figure Consumption (K Unit) and Growth Rate (2015-2026) Figure Different Application Field Consumption Market Share (%) (2019-2020) Table Historical & Forecast Glaucoma Treatment Drugs Different Application Field Consumption (K Unit) Figure North America Glaucoma Treatment Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure North America Glaucoma Treatment Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Glaucoma Treatment Drugs Different Application Field Consumption (K Unit) Figure Asia Glaucoma Treatment Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure Asia Glaucoma Treatment Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Glaucoma Treatment Drugs Different Application Field Consumption (K Unit) Figure Europe Glaucoma Treatment Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure Europe Glaucoma Treatment Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Glaucoma Treatment Drugs Different Application Field Consumption (K Unit) Figure Middle East & Africa Glaucoma Treatment Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure Middle East & Africa Glaucoma Treatment Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Glaucoma Treatment Drugs Different Application Field Consumption (K Unit) Figure South America Glaucoma Treatment Drugs Consumption (K Unit) and Growth Rate (2015-2026) Figure South America Glaucoma Treatment Drugs Consumption Market Share (%) by Application (2015-2026) Table Historical & Forecast Glaucoma Treatment Drugs Different Application Field Consumption (K Unit) Table US Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Canada Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Mexico Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table China Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Japan Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table India Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Korea Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Southeast Asia Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Germany Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table UK Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table France Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Russia Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Italy Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Saudi Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table UAE Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Egypt Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Nigeria Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table South Africa Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Brazil Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Argentina Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Colombia Glaucoma Treatment Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold Figure Proportion of Products Sold (%) (2015 -2026) Table Market Price (USD/Unit) for Each Type of Glaucoma Treatment Drugs in China Table Market Price (USD/Unit) for Each Type of Glaucoma Treatment Drugs in EU Table Market Price (USD/Unit) for Each Type of Glaucoma Treatment Drugs in USA Table Market Price (USD/Unit) for Each Type of Glaucoma Treatment Drugs in Japan Table Market Price (USD/Unit) for Each Type of Glaucoma Treatment Drugs in India Table Market Price (USD/Unit) for Each Type of Glaucoma Treatment Drugs in Southeast Asia Table Market Price (USD/Unit) for Each Type of Glaucoma Treatment Drugs in South America Figure Value Chain Structure of Glaucoma Treatment Drugs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Glaucoma Treatment Drugs Figure Cost Structure of Glaucoma Treatment Drugs in 2020 Table Distributors/Traders List Table ??Aerie Pharmaceuticals Profiles Table ??Aerie Pharmaceuticals Glaucoma Treatment Drugs Product Introduction Figure ??Aerie Pharmaceuticals Glaucoma Treatment Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ??Aerie Pharmaceuticals SWOT Analysis Table ????Akorn Inc. Profiles Table ????Akorn Inc. Glaucoma Treatment Drugs Product Introduction Figure ????Akorn Inc. Glaucoma Treatment Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Akorn Inc. SWOT Analysis Table ????Alcon Profiles Table ????Alcon Glaucoma Treatment Drugs Product Introduction Figure ????Alcon Glaucoma Treatment Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Alcon SWOT Analysis Table ????Allergan plc Profiles Table ????Allergan plc Glaucoma Treatment Drugs Product Introduction Figure ????Allergan plc Glaucoma Treatment Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Allergan plc SWOT Analysis Table ????Bausch & Lomb Incorporated Profiles Table ????Bausch & Lomb Incorporated Glaucoma Treatment Drugs Product Introduction Figure ????Bausch & Lomb Incorporated Pharma & Healthcare Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Bausch & Lomb Incorporated SWOT Analysis Table ????Inotek Pharmaceuticals Profiles Table ????Inotek Pharmaceuticals Glaucoma Treatment Drugs Product Introduction Figure ????Inotek Pharmaceuticals Glaucoma Treatment Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Inotek Pharmaceuticals SWOT Analysis Table ????Merck & Co. Inc Profiles Table ????Merck & Co. Inc Glaucoma Treatment Drugs Product Introduction Figure ????Merck & Co. Inc Glaucoma Treatment Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Merck & Co. Inc SWOT Analysis Table ????Pfizer Inc Profiles Table ????Pfizer Inc Glaucoma Treatment Drugs Product Introduction Figure ????Pfizer Inc Glaucoma Treatment Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020) Figure ????Pfizer Inc SWOT Analysis Table ????Santen Pharmaceutical Co. Ltd Profiles Table ????Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Product Introduction Figure ????Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
